Biogen (BIIB) PT Lowered to $221 at Mizuho

June 15, 2026 6:38 AM

Mizuho analyst Salim Syed lowered the price target on Biogen (NASDAQ: BIIB) to $221.00 (from $236.00) while maintaining a Outperform rating.

No results found